Literature DB >> 2612745

Malignant peritoneal mesothelioma: a series of 19 cases.

T van Gelder1, H C Hoogsteden, M A Versnel, P H de Beer, J P Vandenbroucke, H T Planteydt.   

Abstract

The clinical data, diagnostic procedures and survival are reported in 19 cases diagnosed as malignant peritoneal mesothelioma. All patients were men and 74% had an occupational exposure to asbestos, whereas in 26% no information about asbestos exposure was available. The median interval between asbestos exposure and the diagnosis appeared to be 44.7 years (range 18-49 years). The most common presenting symptoms were abdominal pain, weight loss and dysphagia. Most patients presented with a large amount of ascites. In the majority of patients no therapy except pain relief was given and the median survival from the time of diagnosis was 6 months (range: 0-29 months). Some patients received surgery or chemotherapy, which however did not prolong survival. Only in 2 patients survival exceeded 1 year, although these patients did not receive therapy. The autopsy findings of some patients showed that there were positive abdominal lymph nodes in 2 of them, while in no case positive thoracic lymph nodes were found. The relative short survival period from the time of the first diagnosis in contrast to malignant pleural mesotheliomas is probably the reason for the absence of distant metastases. In this series only in a minority of patients cytology of the ascites was positive and often a laparotomy had to be done. Since cytologic specimens are often negative, we suggest that in patients suspected of a malignant peritoneal mesothelioma, laparoscopy with directed biopsies is the diagnostic procedure of first choice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612745     DOI: 10.1159/000199880

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

Review 1.  Malignant peritoneal mesothelioma: a review.

Authors:  Joseph Kim; Shanel Bhagwandin; Daniel M Labow
Journal:  Ann Transl Med       Date:  2017-06

2.  Parasternal lymph node metastasis of malignant peritoneal mesothelioma: report of a case.

Authors:  Shinya Ito; Noritaka Isowa; Mio Li; Seiki Hasegawa; Hiromi Wada
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Lymphangitis carcinomatosa complicating primary malignant peritoneal mesothelioma.

Authors:  P S Craft; M S Reading; S Jain; R A O'Neil
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

Review 4.  Advances in the management of peritoneal mesothelioma.

Authors:  Ali Raza; Wei-Ching Huang; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

5.  Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.

Authors:  Aaron U Blackham; Edward A Levine
Journal:  European J Clin Med Oncol       Date:  2012-07

6.  Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with a multimodality approach.

Authors:  C J Langer; N Rosenblum; M Hogan; S Nash; P Bagchi; F P LaCreta; R Catalano; R L Comis; P J O'Dwyer
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Peritoneal mesothelioma.

Authors:  W D Kealey; S Dace; W J Campbell; R J Moorhead
Journal:  Ulster Med J       Date:  1993-10

8.  A case of mesothelioma masquerading pre-operatively as ovarian cancer and brief review of the literature.

Authors:  K L Hancock; C M Clinton; H E Dinkelspiel; J Saab; B Schneider; T A Caputo
Journal:  Gynecol Oncol Rep       Date:  2016-04-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.